Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/07/21
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 01/06/20
End: 03/31/27
Due: 03/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer | NCT04872166 | Edgewood Oncology Inc. | user2@example.com | None | 2021-06-07 | 2027-05-31 | 2028-05-31 | - | - | 2025-07-14 |
| A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | NCT04243785 | Edgewood Oncology Inc. | user2@example.com | None | 2020-01-06 | 2027-03-31 | 2028-03-31 | - | - | 2025-07-14 |